KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $8.9 billion.

  • Organon's Non-Current Assets rose 1070.54% to $8.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $35.3 billion, marking a year-over-year increase of 1420.06%. This contributed to the annual value of $8.8 billion for FY2024, which is 1593.38% up from last year.
  • According to the latest figures from Q3 2025, Organon's Non-Current Assets is $8.9 billion, which was up 1070.54% from $8.9 billion recorded in Q2 2025.
  • Over the past 5 years, Organon's Non-Current Assets peaked at $8.9 billion during Q2 2025, and registered a low of $6.7 billion during Q1 2021.
  • Over the past 5 years, Organon's median Non-Current Assets value was $7.0 billion (recorded in 2023), while the average stood at $7.5 billion.
  • As far as peak fluctuations go, Organon's Non-Current Assets crashed by 229.8% in 2022, and later skyrocketed by 1618.05% in 2025.
  • Over the past 5 years, Organon's Non-Current Assets (Quarter) stood at $6.9 billion in 2021, then grew by 1.49% to $7.0 billion in 2022, then rose by 7.49% to $7.6 billion in 2023, then rose by 15.93% to $8.8 billion in 2024, then increased by 1.13% to $8.9 billion in 2025.
  • Its Non-Current Assets was $8.9 billion in Q3 2025, compared to $8.9 billion in Q2 2025 and $8.8 billion in Q1 2025.